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1. Introduction 
1.1 Clinical and pathological aspects of Parkinson’s disease  
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, affecting 
millions of people worldwide (Dorsey, Constantinescu et al. 2007). While some cases of 
familial PD have been reported, the etiology of most cases is still unknown. Significant 
progress in understanding the pathophysiology of PD has been made from genetic and 
epidemiologic studies that have implicated defects in a few key biological processes as 
potential final common pathological pathways. 
PD is a progressive motor disorder characterized by death of dopaminergic neurons in the 
region of the brain called the substantia nigra pars compacta although other areas of the 
central and peripheral nervous system are involved (Braak, Del Tredici et al. 2003). The loss 
of dopaminergic neurons in PD leads to motor symptoms that include akinesia (inability to 
initiate movement), bradykinesia (slowness of movement), resting tremor, and balance 
problems. Non-motor symptoms can include cognitive impairments, mood disturbances, 
sleep dysfunction, gastrointestinal problems, and dysautonomia. PD is a progressive 
disorder and despite several effective therapies that treat many of the symptoms, there are 
no treatments that alter disease progression. Uncovering the causes of PD is likely necessary 
to find effective disease modifying therapies.  
The pathological hallmark of PD is the presence of Lewy bodies, which are cytosolic 
inclusions with several molecular components although -synuclein (-syn) is the 
predominant protein (Spillantini, Schmidt et al. 1997). Lewy bodies also contain ubiquitin, a 
polypeptide that targets proteins to the ubiquitin proteasome system (UPS) for degradation.  
1.2 Genes versus environment 
Despite the elucidation of approximately 18 genes in familial PD and the identification of 
multiple risk factor genes using genome wide association studies on thousands of patients, 
only a small fraction of PD risk has been accounted for (Hardy 2010). Thus, environmental 
factors almost certainly play a major role in the pathogenesis of PD.  
One of the first important clues that the environment may contribute to the pathogenesis of 
PD came in 1982 from the observation that a street drug contained a contaminant called 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) which caused almost overnight a 
clinical syndrome resembling PD. It was subsequently found that MPTP killed 
dopaminergic neurons by being converted enzymatically to MPP+, specifically entering 
dopamine neurons via the dopamine transporter, and inhibiting complex I in the 
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mitochondrial respiratory chain. Notably, the chemical structure of the MPTP metabolite 
MPP+ is similar to paraquat, a commonly used pesticide. These and other observations led 
to a series of epidemiologic studies probing pesticides as potential contributors to the 
etiology of PD. 
Although genetics hasn’t found the cause of 95% of PD cases, the identification of specific 
genes and their functions have provided important clues into pathological processes that 
appear to be involved in non-genetic forms of PD. For example, mutations in the -syn gene 
led to the finding that -syn is the major component of Lewy bodies. Mutations in other 
genes have identified dysfunction of protein degradation (the UPS and autophagy) as 
possibly being involved in the pathogenesis of PD. Since other PD genes are involved in 
mitochondrial function and MPTP inhibits oxidative respiration, mitochondrial dysfunction 
also has been implicated in the pathogenesis of PD. We believe that environmental toxins 
may increase the risk of PD by causing dysfunction in these cellular processes. Here, we will 
review the evidence that pesticides are associated with the development of PD and the 
mechanisms by which they might act. 
2. Pathophysiology of Parkinson’s disease 
2.1 Lewy bodies and -synuclein homeostasis 
Lewy bodies are the pathological hallmark of PD and the major component of these 
intracytosolic inclusions is -syn (Spillantini, Schmidt et al. 1997). -Syn exists in multiple 
forms including soluble monomers, oligomers and fibrils. The multimeric forms appear to 
be the toxic species and their formation is dependent on several factors including amino acid 
substitutions due to mutations in its gene, -syn concentration, and the presence of 
dopamine and dopamine adducts (Li, Lin et al. 2005; Mazzulli, Armakola et al. 2007; Burke, 
Kumar et al. 2008). Exogenous factors such as pesticides have also been reported to increase 
-syn aggregation. Given that -syn aggregation appears central to the pathogenesis of PD 
and pesticides appear to promote this process via a variety of mechanisms, we will briefly 
discuss -syn homeostasis. 
2.1.1 -Synuclein  
-Syn is a predominantly neuronal protein that was first implicated in the development of 
Alzheimer’s disease. The identification of three mutations—A53T, A30P, and G188A—in its 
gene in a few families with dominantly-inherited PD led to the finding that fibrillar -syn is 
the major component of Lewy bodies not only in these patients but also in sporadic PD 
(Nussbaum and Polymeropoulos 1997; Spillantini, Schmidt et al. 1997; Kruger, Kuhn et al. 
1998; Trojanowski, Goedert et al. 1998; Giasson, Jakes et al. 2000). Overexpression of normal -
syn by gene multiplication causes fairly typical PD (Farrer, Kachergus et al. 2004), and people 
who have an -syn promoter that confers a higher level of expression are at higher risk of 
developing PD (Pals, Lincoln et al. 2004; Mueller, Fuchs et al. 2005). Thus, increased levels of 
normal -syn increases one’s risk of getting PD and if it is high enough, it causes it. 
Importantly with respect to this review, certain pesticides can cause -syn levels to increase 
providing a theoretical mechanism to contribute to PD (see below for individual pesticides). 
Furthermore, pesticides can directly increase the rate of -syn fibril formation adding another 
method they can contribute to the pathogenesis of PD (Uversky, Li et al. 2001). 
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2.1.2 Ubiquitin-proteasome system dysfunction in Parkinson’s disease 
-Syn concentrations are determined by the relative amount of its expression and 
degradation, and the higher the concentration, the more likely it is to form aggregates. Both 
the ubiquitin-proteasome system (UPS) and autophagy have been shown to degrade -syn. 
The soluble form appears to be degraded by the UPS while the lysosomal pathway appears 
to degrade aggregated forms of the protein (Liu, Corboy et al. 2003; Cuervo, Stefanis et al. 
2004; Zhang, Tang et al. 2008; Mak, McCormack et al. 2010). The UPS is a highly regulated 
ATP-dependent degradative multi-subunit pathway that helps clear the cell of damaged, 
misfolded or otherwise unneeded proteins. Proteins are targeted to the UPS by ubiquitin-
activating enzymes (E1), ubiqutin-conjugating enzymes (E2), and ubiquitin-protein ligases 
(E3). Once polyubiquitinated, proteins are recognized by the 19S regulatory complex of the 
26S proteasome and translocated to the 20S complex for degradation. Finally, ubiqutin is 
recycled via thiol proteases called deubiquitinating enzymes, which fall into the ubiquitin 
carboxyl-terminal hydrolase (UCH) or ubiquitin-specific processing protease (UBP) families 
(Goldberg 2003). 
Three known genetic causes of PD involve aspects of UPS function. Parkin gene mutations 
cause autosomal recessive PD and is an E3 ubiquitin ligase necessary for targeting proteins 
for degradation. UCH-L1 gene mutations cause autosomal dominant (AD) PD and UCH-L1 
is necessary for the recycling of ubiquitin. Finally, -syn is a substrate for the UPS and 
mutations and duplication of its gene cause AD PD. There is also evidence that UPS 
dysfunction is involved in sporadic PD. Reduced UPS activity has been found in brains of 
PD patients (McNaught and Jenner 2001) and some investigators have found that 
administration of UPS inhibitors to rodents can recreate some of the features of PD although 
these models remain controversial (Bove, Zhou et al. 2006; Kordower, Kanaan et al. 2006; 
Manning-Bog, Reaney et al. 2006; McNaught and Olanow 2006; Schapira, Cleeter et al. 2006; 
Zeng, Bukhatwa et al. 2006). Finally, we have found that several commonly used pesticides 
inhibit the UPS and are associated with an increased risk of developing PD (Wang, Li et al. 
2006; Chou, Maidment et al. 2008). 
2.1.3 Autophagy and Parkinson’s disease 
Autophagy is a cellular process that involves protein and organelle degradation. 
Dysfunction of autophagy has long been known to be involved in disease but only 
recently has been implicated in the pathogenesis of PD. Gaucher’s disease is an autosomal 
recessive lysosomal storage disease caused by mutations in its gene that lead to 
dysfunction of autophagy and are associated with a marked increased risk of developing 
typical PD with Lewy bodies (Aharon-Peretz, Rosenbaum et al. 2004; Neumann, Bras et al. 
2009; Sun, Liou et al. 2010). Another autosomal recessive Parkinsonian disorder (PARK9) 
is caused by a mutation in another lysosomal gene, ATP13A2 (Ramirez, Heimbach et al. 
2006). PINK1 has also been shown to be a modifier of autophagy and mutations in its 
gene cause PD with Lewy bodies (PARK6) (Narendra, Jin et al. 2010; Samaranch, Lorenzo-
Betancor et al. 2010). Additional evidence for a role of autophagy in PD comes from 
studies of sporadic PD brains where increased numbers of autophasomes have been 
described (Anglade, Vyas et al. 1997).  
α-Syn clearance is likely carried out by both the UPS and autophagy. Large aggregates of α-
syn proteins are likely degraded by macroautophagy but soluble α-syn can undergo 
degradation via an alternate lysosomal pathway, chaperone-mediated autophagy (CMA) 
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(Massey, Zhang et al. 2006). α-Syn has also been found to inhibit lysosomal macroautopaghy 
and oligomers are resistant to CMA adding further support for a possible role of protein 
degradation dysfunction in the pathogenesis of PD (Martinez-Vicente, Talloczy et al. 2008).  
2.2 Mitochondrial dysfunction and oxidative stress 
The role of mitochondrial dysfunction in the pathophysiology of PD was first suggested by 
the discovery that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin 
selective for nigral dopaminergic neurons, acts through inhibition of complex I of the 
electron transport chain. MPTP is converted by monoamine oxidase (MAO-B) to its toxic 
metabolite 1-methyl-4-phenylpyridinium (MPP+), which is rapidly concentrated by 
dopaminergic neurons into the mitochondria and produces cell death (Langston, Ballard et 
al. 1983; Chiba, Trevor et al. 1985; Javitch, D'Amato et al. 1985; Gainetdinov, Fumagalli et al. 
1998). This discovery led to the findings that complex I activity is reduced not only in brains 
of PD patients but also in peripheral mitochondria (Schapira, Cooper et al. 1990; Haas, 
Nasirian et al. 1995). Furthermore, mutations in some genes that code for mitochondrial 
associated proteins can cause PD (e.g. DJ1 and PINK1) and chronic systemic administration 
of complex I inhibitor (rotenone) in rodents reproduces many of the clinical and 
pathological aspects of PD (Betarbet, Sherer et al. 2000).  
It is still unclear what are the downstream targets of mitochondrial dysfunction. ATP 
depletion is not necessary in the rotenone rodent model for its toxicity but the generation of 
reactive oxygen species (ROS) appears to be essential. ROS are known to oxidize DNA, 
lipids and proteins to cause cellular damage. Interestingly, ROS from complex I inhibition 
leads to UPS inhibition (Chou, Li et al. 2010). Furthermore, the formation of ROS from 
complex I inhibition likely contributes to the Lewy-like bodies observed in the rotenone 
model (Betarbet, Canet-Aviles et al. 2006).  
2.2.1 Aldehyde dehydrogenase (ALDH) inhibition 
Another form of mitochondrial dysfunction implicated in PD involves the inhibition of 
aldehyde dehydrogenase 2 (ALDH2), a mitochondrial ALDH. This enzyme is responsible 
for the detoxification of aldehydes that could otherwise modify proteins. For example, the 
lipid peroxidation product 4-hydroxy-2-nonenal (HNE) is detoxified by ALDH2 and 
increased HNE has been reported in post mortem PD brains as adducts (Yoritaka, Hattori et 
al. 1996) and as a component of Lewy bodies (Castellani, Perry et al. 2002). Furthermore, 
HNE has been shown to prevent -syn fibrillation and form -syn oligomers, which are 
toxic to primary mesencephalic cultures (Qin, Hu et al. 2007). Another ALDH2 substrate, the 
dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL), has also been reported to 
induce -syn aggregation and be toxic to dopaminergic neurons (Burke, Kumar et al. 2008). 
ALDH involvement in the pathogenesis of PD is not yet well established but preliminary in 
vitro and epidemiology studies have implicated this enzyme as a possible mediator of some 
pesticides’ toxicity (see benomyl below). 
2.3 Altered dopamine homeostasis 
Conventional wisdom in the pathophysiology of PD is that dopaminergic neurons are 
selectively vulnerable, although more recent evidence suggests that neuronal loss is more 
widespread. One hypothesis for this possible vulnerability is via the metabolism of 
dopamine itself (Hastings 2009).  
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Dopamine and its metabolites are toxic and dopamine adducts have been shown to stabilize 
-syn oligomers. DOPAL, a substrate for ALDH2, is particularly toxic. Interestingly, 
DOPAL is formed by the enzyme MAO-B and blocking this enzyme with specific drugs 
appears to alter the progression of PD (Olanow, Rascol et al. 2009). Thus, alterations in 
levels of dopamine or its metabolites might contribute to neuronal loss. Increased levels of 
VMAT2, a vesicular transporter that lowers cytosolic dopamine levels, lowers the risk of 
developing PD (Glatt, Wahner et al. 2006). Further support for altered dopamine 
homeostasis in PD comes from a recent report that polymorphisms in the dopamine 
transporter (DAT) gene in combination with pesticide exposure also increases the risk of PD 
(Ritz, Manthripragada et al. 2009). 
Taken together, dysfunction of several cellular processes appears to contribute to the 
pathogenesis of PD. Aggregation of -syn (oligomerization and possibly fibril formation) is 
the leading candidate for the final common pathway for neurons to die in PD. There is 
evidence that pesticides cause dysfunction in many of these processes providing potential 
mechanisms for their toxicity (Figure 1).  
 
 
Fig. 1. Proposed pathophysiology of Parkinson’s disease. 
3. Epidemiology of Parkinson’s disease 
3.1 Environment and Parkinson’s disease 
Over the past two decades, several epidemiologic studies have identified a number of 
environmental factors that are associated with an altered risk of developing PD. Smoking 
tobacco is almost universally found to be associated with a lower risk of developing the 
disease (Ritz, Ascherio et al. 2007). Caffeine and alcohol consumption have also been 
associated with a reduced risk of PD (Hellenbrand, Seidler et al. 1996). Since all of these 
addictive behaviors are associated with reduced incidence, it has been proposed that they 
may be surrogate markers for a common behavioral phenotype of pre-clinical PD patients 
rather than these exposures all being protective. The use of nonsteroidal anti-inflammatory 
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drugs has also been found to reduce the risk of PD suggesting inflammation may be 
somehow involved in its pathogenesis (Wahner, Bronstein et al. 2007). 
A number of studies have found strong associations between an increased risk of PD and 
rural living, well-water consumption, farm occupations, and pesticide exposure. These 
reports have been reviewed extensively by others so we will not review all the studies here 
(Le Couteur, McLean et al. 1999; Di Monte 2003; Alavanja, Hoppin et al. 2004; Kamel and 
Hoppin 2004; Li, Mink et al. 2005; Brown, Rumsby et al. 2006). The association with pesticide 
exposure has been the most provocative association with developing PD to date although 
almost all of these reports were based on self-reporting pesticide exposure (i.e. potential 
recall bias) and the diagnosis of PD was not confirmed (Gartner, Battistutta et al. 2005). 
Despite these weaknesses, a meta-analysis of case–control studies obtained a combined odds 
ratio (OR) for PD risk of 1.94 (95% CI, 1.49–2.53) (Priyadarshi, Khuder et al. 2000). 
Subsequent studies reported OR of up to 7.0 (Brown, Rumsby et al. 2006). 
Recently, the issue of potential recall bias was mitigated by determining pesticide exposure 
in a prospective manner. Petrovitch et al reported an increased risk of developing PD in 
Japanese-American men who worked on a plantation and were exposed to pesticides 
(Petrovitch, Ross et al. 2002). Similarly, Ascherio et al found a 70% increased risk of 
developing PD in those who reported significant pesticide exposure (Ascherio, Chen et al. 
2006). These reports add support for a true association between pesticides and PD but still 
are limited in that they did not identify individual toxins and dose response relationships 
could not be determined. 
3.2 Specific pesticides as risk factors 
There are a few ongoing studies that address both the issue of recall bias and are identifying 
specific pesticides that confer an altered risk of developing PD. The Agricultural Health 
Study (AHS) is a prospective study, including 84,740 private pesticide applicators (mostly 
farmers) and their spouses recruited in 1993-97 in Iowa and North Carolina. Pesticide 
exposure was self-reported but felt to be reliable. The diagnosis of PD was also self-reported 
but later confirmed by direct examination. The first report from this study found an 
association between PD with increasing lifetime days of use of any pesticide but no specific 
pesticide could be definitely implicated due to lack of statistical power (Kamel, Tanner et al. 
2007). Recently, the investigators reported that PD was associated with rotenone (OR 2.5, 
95% CI 1.3, 4.7) and paraquat use (OR 2.5, 95% CI 1.4, 4.7) (Tanner, Kamel et al. 2011). The 
strength of this study is that it is prospective, the diagnosis was confirmed by examination, 
and specific toxins were identified. The primary weakness of this study is that they have 
only 110 cases limiting their power to test a number of pesticides individually and in 
combinations. The small number of cases also limits their ability to test gene-environment 
interactions. One additional limitation was that quantitation of pesticide exposure, types of 
exposure and length of exposures were self-reported. Despite these shortcomings, this study 
adds strong epidemiological evidence that pesticides are associated with an increased risk of 
developing PD, especially for rotenone and paraquat.  
Ritz and colleagues at UCLA have taken another approach to identifying specific pesticides 
that are associated with an altered risk of PD. We took advantage of the California Pesticide 
Use Reporting database and Geographic Information System land-use maps to estimate 
historical exposure. All commercial pesticide applications have been recorded by 
compound, quantity, and specific location since 1974. Thus, individual subject exposures 
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can be approximated by using their residential and occupational addresses for the past 37 
years. In this Parkinson’s Environment Gene (PEG) study, neurologists specializing in 
movement disorders went into the field to confirm the diagnosis in over 350 incident PD 
cases in the central California valley where pesticides are applied liberally and the risk of 
PD appears to be increased (Ritz and Yu 2000; Kang, Bronstein et al. 2005). A similar number 
of age and sex matched control subjects were also recruited from the same communities. In 
addition to several lifestyle and medical assessments, DNA and serum samples were also 
obtained.  
Individual pesticides were investigated in the PEG study based on previous reports 
implicating the agents as possibly involved in the pathogenesis of PD based on previous 
epidemiologic and/or laboratory studies. Maneb and paraquat were investigated because 
administration of pesticides to rodents produces a nice model of PD (see below). Estimates 
for maneb and paraquat exposures incurred between 1974 and 1999 were generated based 
on their residence. Exposure to both pesticides within 500m of their homes increased PD 
risk by 75% (95% CI 1.13, 2.73). Subjects aged ≤ 60 yo were at much higher risk of 
developing PD when exposed to either maneb or paraquat alone (odds ratio (OR) = 2.27, 
95% CI: 0.91, 5.70) or to both pesticides in combination (OR = 4.17, 95% CI: 1.15, 15.16) 
(Costello, Cockburn et al. 2009). PEG investigators have found similar associations with 
organophospate pesticides—diazinon (OR 1.73, CI 1.23, 2.45) and chlorpyrifos (OR 1.50, CI 
1.04, 2.18) (Manthripragada, Costello et al. 2010)—and ziram (OR 3.01, CI 1.69, 5.38). In 
subjects ≤ 60 yo, exposure to both ziram and paraquat had a 6-fold increase in risk of PD (CI 
1.94, 18.33) (Wang, Costello et al. 2011). It is important to note that all estimates of exposures 
were not dependent on subject recall for total exposure or duration of exposure. Recent 
exposure to pesticides (1990 to 1999) was not generally associated with an increased risk of 
PD consistent with the theory that PD pathology likely starts several years before it 
manifests itself clinically.  
The population is exposed to pesticides in a variety of ways, not just inhalation from 
spraying and crop dusters. Gatto et al. looked at five pesticides that were likely to be 
detected in well water (Gatto, Cockburn et al. 2009). Although local well water was not 
analyzed, these pesticides were identified based on their solubility, half-lives, and 
adsorptive properties. These included organophosphates (diazinon, dimethoate, 
chlorpyrifos), a carbamate (methomyl), and a sulfite ester (propargite). Excluding those who 
did not consume well water, potential inhalation and ingestion of each pesticide was 
associated with 23-57% increased risk of PD. Consuming well water potentiated this effect to 
a 41-75% increased risk. Up to a two-fold increase was observed for those who consumed 
water with the highest potential contamination of at least one of these pesticides. Finally, 
those with PD were found to have consumed well water an average of 4.3 years longer than 
controls. Because PEG has enrolled over 350 cases, we have statistical power to test gene-
environment interactions. Not surprisingly, the risk of developing PD in pesticide-exposed 
subjects is clearly altered based on the subject’s genetic background (see below). 
3.3 Gene-environment interactions 
Gene–environment interaction analyses for pesticides and PD have been rare due to small 
sample size and difficulty obtaining exposure data (Deng, Newman et al. 2004; Elbaz, 
Levecque et al. 2004; Kelada, Checkoway et al. 2006; Hancock, Martin et al. 2008). Elbaz et al 
found that pesticides had a modest effect in subjects who were not CYP2D6 poor 
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metabolizers, had an increased effect in poor metabolizers (approximately twofold), but 
poor metabolizers were not at increased PD risk in the absence of pesticide exposure (Elbaz, 
Levecque et al. 2004). Hancook et al found a gene-environment association in PD for 
pesticides and nitric oxide synthase 1 polymorphisms (Hancock, Martin et al. 2008). Kelada 
et al described a very modest risk of developing PD with specific dopamine transporter 
(DAT) alleles but a 5.7 fold increase (CI 1.73-18.53) in developing PD in subjects with 
occupational exposure to pesticides. These studies added proof of concept that the effect of 
environmental exposures on the risk of developing PD is at least partially dependent on 
one’s genetic background (Kelada, Checkoway et al. 2006). Unfortunately, exposure 
assessments were very limited in all of these studies and individual toxins could not be 
determined.  
Gene-environment analysis in Ritz’s PEG study has only recently begun but has already 
revealed intriguing results. We replicated the DAT polymorphism’s interaction with 
pesticide exposure described by Kelada et al for at least maneb and paraquat (Ritz, 
Manthripragada et al. 2009). Unexposed subjects with more susceptibility alleles had a 30% 
increased risk of developing PD whereas exposed subjects had an almost five-fold increased 
risk (OR = 4.53; 95% CI, 1.70-12.1). Importantly, there was a gene dose effect as well. In a 
similar manner, variations in PON1, the gene that encodes Paraoxonase 1 that metabolizes 
chlorpyrifos and diazinon, potentiated the increased PD risks associated with these 
organophosphates (Manthripragada, Costello et al. 2010).  
For example, diazinon was associated with a 73% increased risk of PD (CI 1.23, 2.45) but the 
risk increases to 267% (CI 1.09, 6.55) in individuals who carry PON1 risk alleles. Variations 
in the dinucleotide repeat sequence (REP1) within the α-syn promoter appear to alter the 
risk to paraquat exposure (Gatto et al., 2010). Finally, we have preliminary evidence that 
variations in ALDH2 gene potentiate the increased risks associated with dithiocarbamates 
and other pesticides that inhibit ALDH activity (Fitzmaurice, Rhodes et al. 2010).  
Clearly, the number of potential gene-environment interactions is enormous but we have 
clear proof of concept that these interactions need to be considered to truly understand 
environmental risks in PD. It will take very large sample sizes and good exposure analysis 
to obtain a better understanding of the many potential interactions that confer the bulk of 
PD risk factors. Alternatively, a candidate gene approach coupled with a better 
understanding of the pharmacokinetics and toxicity of specific pesticides may allow us to 
test gene-environment interactions using smaller sample sizes.  
4. From association to causality - do pesticides cause PD and if so, how? 
Epidemiological studies have clearly established the association between pesticide exposure 
and the development of PD. The possibility that this association represents causality has 
been strengthened by recent studies that addressed the problem of recall bias and have 
demonstrated a dose-effect relationship. Now that some individual pesticides have been 
implicated, mechanistic studies could be pursued. These studies are reviewed within the 
context of our current understanding of the pathophysiology of PD.  
4.1 Rotenone 
Rotenone is produced naturally in roots of certain plant species such as the jicama vine. It 
is a widely used domestic garden pesticide and because it is degraded by the sun in a 
matter of days, users tend to spray rotenone frequently. Rotenone is also a well-
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characterized, high-affinity, specific inhibitor of complex I of the mitochondrial 
respiratory electron transport chain. Low complex I activity had been reported to be 
associated with PD both in brain and peripheral mitochondria but it wasn’t known 
whether this is causal or a surrogate marker for something else. To further investigate 
this, Greenamyre and colleagues chronically administered the complex I inhibitor, 
rotenone, systemically into rodents. Some of these rats developed selective dopaminergic 
neuronal death as well as many of the motor features of PD. Importantly, neurons 
developed intracytoplasmic inclusions that were found to contain α-syn (Betarbet, Sherer 
et al. 2000). α-Syn pathology in the gastro-intestinal tract has also been described in the 
rotenone model similar to that seen in PD (Drolet, Cannon et al. 2009). Even small 
amounts of rotenone delivered intragastrically reproduces many of the same features 
described in rats given rotenone subcutaneously but in this model, the various stages of 
PD are reproduced in a progressive manner (Pan-Montojo, Anichtchik et al. 2010).  
The mechanisms of rotenone toxicity are not completely clear but likely are more 
dependent on oxidative stress than energy failure (Sherer, Betarbet et al. 2002). The 
downstream targets of rotenone-induced oxidative damage are likely vast but the UPS 
appears to be one of them (Betarbet, Canet-Aviles et al. 2006; Wang, Li et al. 2006; Chou, Li 
et al. 2010). 
Until recently, there have not been convincing epidemiologic reports linking rotenone 
exposure to PD. Dhillon et al reported an over 10 fold increase in risk although this study 
was limited because exposures were self-reported (Dhillon, Tarbutton et al. 2008). The 
Agricultural Health Study did find a 2.5 fold increased risk with prospective questionnaires 
adding further support for rotenone as a PD risk factor (Tanner, Kamel et al. 2011). 
Furthermore, many organic farmers in the 1970s used rotenone as a natural pesticide and a 
number of them have developed PD at a young age although scientific confirmation of these 
anecdotal reports is lacking. Other pesticides that are complex I inhibitors are used even less 
frequently than rotenone so little is known about associations with PD although one would 
predict a similar effect. 
4.2 Paraquat 
One of the first pesticides investigated for its potential link to PD was paraquat due to its 
structural similarity to MPTP, the drug that caused acute Parkinsonism in drug addicts. 
MPTP kills dopaminergic neurons by being metabolized to MPP+ by MAO-B, entering 
dopamine cells via the dopamine transporter and then inhibiting complex I in the 
mitochondrial respiratory chain. Paraquat is ubiquitously used as an herbicide to control 
weed growth and exposure to paraquat is associated with an increased risk of PD 
(Hertzman, Wiens et al. 1990; Semchuk, Love et al. 1992; Liou, Tsai et al. 1997).  
Additional support for paraquat increasing the risk of PD comes from animal studies. Mice 
infused with paraquat for three consecutive weeks exhibit dopamine cell loss and cytosolic 
α-syn aggregates (Brooks, Chadwick et al. 1999; Manning-Bog, McCormack et al. 2002; 
McCormack, Thiruchelvam et al. 2002). The mechanism by which paraquat causes 
dopamine cell death is not clear. Since it is structurally very similar to MPTP, it was 
presumed that paraquat acted in a similar manner. Surprisingly, unlike MPP+, paraquat is 
not a substrate for the dopamine transporter and does not inhibit complex I except at very 
high concentrations (Richardson et al 2005). Paraquat toxicity does appear to be dependent 
on increasing oxidative stress and its action as a redox-cycler appears likely involved in its 
toxicity (McCormack, Atienza et al. 2005). 
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4.3 Dithiocarbamates (maneb and ziram) 
Dithiocarbamates (DTCs) are a class of some of the most commonly used organic fungicides. 
They are classified into 2 groups based on whether there is a carbonyl (group 1) or hydrogen 
on the nitrogen carbamate. Most DTCs are complexed with metals including zinc (e.g. ziram 
and zineb), iron (e.g. ferbam) and manganese (e.g. maneb). DTCs first became relevant to 
PD researchers in 1985 when Corsini et al found that diethyldithiocarbamate pretreatment 
enhanced MPTP toxicity in mice (Corsini, Pintus et al. 1985). They proposed that 
diethyldithiocarbamate would potentiate MPTP toxicity by inhibiting superoxide dismutase 
since they believed at that time that MPTP acted primarily as a redox cycler. Thiruchelvam 
et al. later reported that maneb potentiated the toxicity of paraquat preferentially in the 
nigrostriatal dopaminergic system (Thiruchelvam, Brockel et al. 2000; Thiruchelvam, 
McCormack et al. 2003). Furthermore, maneb and paraquat exposure was found to 
exacerbate α-synucleinopathy in A53T transgenic mice (Norris, Uryu et al. 2007).  
The animal models using maneb and paraquat were intriguing but it was only recently that 
an association between maneb and paraquat exposures and PD were reported (Costello, 
Cockburn et al. 2009). Similar to the animals studies, residential exposure to maneb and 
paraquat exposure together is associated with a 114% increased risk of newly diagnosed PD. 
Furthermore, the risk of PD was increased to 317% for cases ≤ 60 yo. Neither pesticide alone 
was associated with PD but there were few subjects with maneb only exposure so that the 
true effect for maneb alone could not be assessed. When both occupational and residential 
exposures are taken into account, subjects exposed to maneb and paraquat alone had a 126% 
and 50% increase in risk of developing PD respectively but for exposure to maneb and 
paraquat together, the risk increased to 8.75x (CI 2.3-33.2) in the younger group (Wang, 
Costello et al. 2011). These epidemiologic data taken together with the animal data are quite 
compelling that these pesticides truly increase the risk of PD.  
As mentioned above, DTCs are a large group of fungicides with similar structures. We 
identified another DTC, ziram, in an unbiased screen to identify pesticides that inhibit the 
proteasome (Wang, Li et al. 2006). Maneb and some other DTCs were also found to inhibit 
the UPS but at higher concentrations (Chou, Maidment et al. 2008). Ziram selectively killed 
dopaminergic neurons in primary cultures and increased -syn levels in the remaining 
neurons. Systemic administration of ziram alone into mice caused progressive motor 
dysfunction and dopaminergic neuronal damage (Chou et al 2008). Furthermore, subjects 
exposed to ziram alone had a 201% (CI 1.69, 5.38) increase of risk of developing PD and a 
598% (CI 1.95, 18.3) increased risk when exposed with paraquat in subjects ≤ 60 yo (Wang, 
Costello et al. 2011). These data add further support for the role of DTCs as a causal risk 
factor for PD. 
It is still not completely clear how DTCs act biologically. We have found that they do not 
increase oxidative stress and therefore are unlikely acting through the mitochondrial 
respiratory chain (Wang, Li et al. 2006). DTCs clearly inhibit the UPS and their potency 
depends on whether they contain a tertiary or a secondary amino group. Ziram was studied 
extensively given its high potency to inhibit the UPS and we found that it acts by interfering 
with the ubiquitin E1 ligase with an IC50 of 161 nM (Chou, Maidment et al. 2008). Zhou et al 
reported that maneb also inhibited the UPS but at higher concentrations (IC50 of approx. 6 
μM) and increased protein carbonyls suggesting increased oxidative stress (Zhou, Shie et al. 
2004). We also found that maneb inhibits the UPS at much higher concentrations than ziram 
but we did not find evidence of oxidative stress. Differences may very well be due to 
differences in the techniques used since we used an in vitro 26S UPS assay and DCF 
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fluorescence to detect ROS and Zhou et al used an in vitro 20S UPS assay and protein 
carbonyl immunohistochemistry for detection of oxidative stress. Recently, we have found 
that both maneb and ziram inhibit ALDH2 at environmentally-relevant concentrations, 
adding another potential mechanism of toxicity, especially to dopaminergic neurons 
(Fitzmaurice, Rhodes et al. 2010). Since ziram does not contain manganese, it is very 
unlikely that it is the manganese in maneb that confers its toxicity as some have suggested. 
4.4 Benomyl 
Another important fungicide implicated in PD pathogenesis is the benzimidazole 
compound benomyl. It was developed as a microtubule inhibitor and is sprayed on fruits, 
nuts, and leaves to prevent fungal growth. Preliminary findings from the PEG study 
revealed benomyl exposure increased PD risk by 138% (CI 1.33, 4.27) (Fitzmaurice, Rhodes 
et al. 2010). 
Benomyl metabolizes spontaneously into another fungicide (carbendazim) and 
enzymatically into several thiocarbmate compounds. We have shown that benomyl and 
carbendazim are UPS inhibitors, although they are not as potent as ziram (Wang, Li et al. 
2006; Fitzmaurice, Ackerman et al. 2010). Furthermore, benomyl has also been reported to 
inhibit mitochondrial ALDH (Staub, Quistad et al. 1998). Although these studies focused on 
hepatic ALDH, we recently reported that benomyl exposure reduced ALDH2 activity ex vivo 
in rat neuronal suspensions (Fitzmaurice, Ackerman et al. 2010). We have also found that 
exposure to benomyl or one of its ALDH2-inhibiting metabolites (S-methyl-N-
butylthiocarbamate, or MBT) causes dopaminergic neuronal death in vitro, while the UPS-
inhibiting metabolite (carbendazim) does not. These findings, combined with the 
observation that DTCs also inhibit ALDH2, suggest that ALDH2 inhibition may be an 
important mechanism in pesticide toxicity with respect to PD. 
The toxicity of ALDH2 inhibition is likely due to the accumulation of toxic aldehydes. We 
would predict that ALDH2 inhibition would lead to increased levels of DOPAL and HNE 
adducts and preliminary studies in primary cultures support this hypothesis. Furthermore, 
the loss of dopaminergic neurons due to benomyl was attenuated by co-treatment with the 
MAO-B inhibitor pargyline which decreases DOPAL formation (Fitzmaurice, Ackerman et 
al. 2010). Since DOPAL and HNE accumulation have been reported to induce α-syn 
aggregation (Burke, Kumar et al. 2008), these findings support ALDH2 inhibition as an 
important mediator of pesticide toxicity in PD.  
5. Summary 
The causes of PD are not completely understood but both genetic and epidemiologic studies 
suggest that dysfunction of one or more biological processes lead to -syn aggregation and 
neuronal death. Epidemiologic studies have clearly shown PD to be associated with 
pesticide exposure and specific pesticides conferring at least some of this increased risk have 
recently been identified. The fact that administration of pesticides to animals recapitulates 
many of the behavioral and pathological features of PD provides evidence that the 
associations found in epidemiologic studies are causal. Elucidating the mechanisms of 
pesticide toxicity in mammals not only strengthens the hypothesis that exposure to these 
toxins can increase the risk of developing PD, but also furthers our understanding of the 
pathophysiology of the disease in general. It is clear that the list of pesticides discussed in 
this chapter is not complete and that pesticides are not the only environmental toxins that 
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alter the risk of PD, but the preponderance of evidence taken together supports an 
important role of pesticides in the pathogenesis of PD. A better understanding of these 
issues will take us one step closer to a cure. 
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Nevertheless, the increase of the pesticide use estimated to 2.5 million tons annually worldwide since 1950.,
created a number of public and environment concerns. This book, organized in two sections, addresses the
various aspects of the pesticides exposure and the related health effects. It offers a large amount of practical
information to the professionals interested in pesticides issues.
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